Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.
- 1439.137
- +10.780+0.75%
Vertex Pharmaceuticals Q3 2024 Earnings Preview
Weekly Buzz: Magnificent Mix of Market Reactions
November Starts with a Climb to end Tough Week | Wall Street Today
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Waters Sends Peers Higher After Q3 Beat, Guidance Raise
Looking Into Agilent Technologies's Recent Short Interest
Friday Market Climbs on Amazon Earnings, Labor Numbers at Four-Year Low | Live Stock
Thursday, Halloween Market Falls in Scary Reaction to Earnings | Wall Street Today
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500
Halloween Market Falls, Scared of Meta and Microsoft CapEx | Live Stock
Jim Cramer: This Financial Stock Is 'One Of The Most Consistent, Great Companies'
Market Flips and Falls as Meta and MSTR Fall After Earnings | Wall Street Today
Vertex Pharmaceuticals Analyst Ratings
Market Climbs, SMCI Auditors Allege Mischief on Mischief Night | Live Stock
Nasdaq Hits Record High While Wed Earnings Are Mixed | Wall Street Today
Price Over Earnings Overview: Agilent Technologies
Tuesday Market Falls on Tough Earnings, With AMD and Alphabet Reporting Tonight | Live Stock
Looking Into Intellia Therapeutics's Recent Short Interest
Slow Day to Start Busy Week | Wall Street Today
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 5 Years